[(η5‐C5R5)TiCl2(η5‐C5H4SiMe2)]2O·nCH2Cl2

The first title metallocene, 1,3‐bis(dichlorotitanocene)‐1,1,3,3‐tetramethyldisiloxane dichloromethane solvate, [(η⁵‐C₅H₅)­TiCl₂­(η⁵‐C₅H₄­Si­Me₂)]₂O·­CH₂Cl₂, (I), crystallizes in space group P2₁/c. Compound (I) represents the first crystal structure of a bimetallic siloxy‐bridged titanocene. The geometric parameters of (I) are similar to those of the parent titanocene; however, the disiloxane substituents adopt an unexpected eclipsed conformation. The second title metallocene, 1,3‐bis­[(penta­methyl­cyclo­penta­dienyl)­(cyclo­penta­dien­yl)­titanium dichloride]‐1,1,3,3‐tetra­methyl­disiloxane, [(η⁵‐C₅‐Me₅)­TiCl₂­(η⁵‐C₅H₄­Si­Me₂)]₂O, (II), represents the second crystal structure of a bimetallic siloxy‐bridged titanocene and crystallizes in the space group P2₁/n. Compound (I) possesses non‐crystallographic twofold molecular symmetry and both metal centers adopt pseudo‐tetrahedral geometries. The geometric parameters of (II) are similar to those of the mixed titanocene Cp*CpTiCl₂ (Cp* = C₅Me₅) and the disiloxane substituents adopt a staggered conformation.     

Syntheses and Anti—inflammatory Actiobn of （η—C5H5）2Ti （Cin）2 and （η—C5H5）2Ti（Tzea）2

Two new Complexes(Cp)2Ti(Cin)2and (CP2)Ti(Tzea)2(CP=Cyclopentadienyl η^5-C5H5)have been synthesized in THF by the reaction of HCin(Cincofen,2-phenylquinoline-4-carboxylic acid)or HTzea(5-phenyltetrazolyl-2-ethanoic acid)with(Cp)2TiCl2,and characterized by elemental analyses,IR,1H NMR and 13C NMR,UV spectra,molar conductivity,TGDTA.In the complexes the carboxyl groups are coordinated to Ti(IV)in a monodentate manner,The inhibitory actions of the complexes on mice ear tumefaction caused by croton oil and the rat foot granulation growth produced by cotton wool are higher than those of the corresponding ligands HCin,HTzea and [(Cp)2TiCl2],while their toxicities are lower than those of the free ligands.ηη     

Chlorido(η5‐cyclopentadienyl)bis(dimethylamido)titanium, [TiCl(η5‐C5H5)(NMe2)2]

The title complex, [Ti(C₅H₅)(C₂H₆N)₂Cl], exhibits two nearly planar dimethylamide groups oriented approximately perpendicular to each other. The Ti→cyclopentadienyl centroid vector lies nearly in the plane of one of the dimethylamide groups. Long‐range contacts between Ti—Cl and cyclopentadienyl H—C groups give rise to geometric ordering in the extended solid.     

2‐Amino‐5‐methyl­pyridinium (2‐amino‐5‐methyl­pyridine)trichloro­zincate(II)

The title compound, (C₆H₉N₂)[ZnCl₃(C₆H₈N₂)], consists of one 2‐amino‐5‐methyl­pyridinium cation and one (2‐amino‐5‐methyl­pyridine)trichloro­zincate(II) anion, which are held together by N—H·Cl hydrogen bonds and π–π inter­actions. The cation and the pyridine ligand show similar geometric features, except for the N—C bond lengths. Mol­ecules of the title compound are connected by N—H·Cl hydrogen bonds to form chiral chains; these chains are associated further by C—H·Cl hydrogen bonds to form layers, which are in turn linked by π–π inter­actions.     

Synthesis of 2′-Deoxyisoguanosine 5′-Triphosphate and 2′-Deoxy-5-methylisocytidine 5′-Triphosphate

The syntheses of the 5′-triphosphates of 2′-deoxyisoguanosine (=p₃isoG_d) and 2′-deoxy-5-methylisocytidine (=p₃me⁵isoC_d), two new bases for the genetic alphabet, are described. The triphosphates were synthesized from the corresponding nucleosides using a transient-protection procedure. The introduction of a methyl group at the 5-position of 2′-deoxyisocytidine remarkably improved the stability of the triphosphate. Characterization of the triphosphates included enzymatic incorporation opposite the complementary base in a template oligonucleotide.     

Synthesen und Eigenschaften von Pentafluorethylkupfer(I)‐ und ‐(III)‐Verbindungen: Cu(C2F5) · D, [Cu(C2F5)2]– und (C2F5)2CuSC(S)N(C2H5)2

Syntheses and Properties of Pentafluoroethylcopper(I) and ‐copper(III) Compounds: CuC₂F₅ · D, [Cu(C₂F₅)₂]^–, and (C₂F₅)₂CuSC(S)N(C₂H₅)₂ The reactions of Cd(C₂F₅)₂ · D and Zn(C₂F₅)₂ · D (D = 2 CH₃CN, 2 DMF), respectively, with copper(I) halides in the presence of halides quantitatively yield the CuC₂F₅ compounds CuC₂F₅ · D and [Cu(C₂F₅)₂]^–. The CuC₂F₅ complexes are identified by NMR spectroscopy, while [Cu(C₂F₅)₂]^– is isolated as PNP salt (PNP = (C₆H₅)₃PNP(C₆H₅)₃⁺). Both compounds are excellent C₂F₅ group transfer reagents, even at low temperature. Oxidation of [Cu(C₂F₅)₂]^– with [(C₂H₅)₂NC(S)S]₂ yields the crystalline Cu(III) compound (C₂F₅)₂CuSC(S)N(C₂H₅)₂ (monoclinic, C2/c).     

Bis(5‐hydroxy‐2‐hydroxy­methyl‐4‐pyrone‐κ2O4,O5)bis(2‐hydroxy­methyl‐5‐oxido‐4‐pyrone‐κ2O4,O5)­calcium(II) tetrahydrate

In the title compound, [Ca(C₆H₅O₄)₂(C₆H₆O₄)₂]·4H₂O, which is a kojic acid–Ca²⁺ complex, the Ca atom is on a twofold axis and is octacoordinated by O atoms from four pyrone ligand mol­ecules. The hydroxyl and ketone O atoms of each ligand form a five‐membered chelate ring with the Ca atom. The crystal structure is stabilized by partial stacking and O—H?O hydrogen bonds.     

Synthesis of (5′S)‐5′‐C‐Alkyl‐2′‐deoxynucleosides

We describe the synthesis of (5′S)‐5′‐C‐butylthymidine ( 5a ), of the (5′S)‐5′‐C‐butyl‐ and the (5′S)‐5′‐C‐isopentyl derivatives 16a and 16b of 2′‐deoxy‐5‐methylcytidine, as well as of the corresponding cyanoethyl phosphoramidites 9a , b and 14a , b , respectively. Starting from thymidin‐5′‐al 1 , the alkyl chain at C(5′) is introduced via Wittig chemistry to selectively yield the (Z)‐olefin derivatives 3a and 3b (Scheme 2). The secondary OH function at C(5′) is then introduced by epoxidation followed by regioselective reduction of the epoxy derivatives 4a and 4b with diisobutylaluminium hydride. In the latter step, a kinetic resolution of the diastereoisomer mixture 4a and 4b occurs, yielding the alkylated nucleoside 2a and 2b , respectively, with (5′S)‐configuration in high diastereoisomer purity (de=94%). The corresponding 2′‐deoxy‐5‐methylcytidine derivatives are obtained from the protected 5′‐alkylated thymidine derivatives 7a and 7b via known base interconversion processes in excellent yields (Scheme 3). Application of the same strategy to the purine nucleoside 2′‐deoxyadenine to obtain 5′‐C‐butyl‐2′‐deoxyadenosine 25 proved to be difficult due to the sensitivity of the purine base to hydride‐based reducing agents (Scheme 4).     

[Co(g5‐Me5C5)(g3‐tBu2PPCH–CH3)] aus [Co(g5‐Me5C5)(g2‐C2H4)2] und tBu2P–P=P(Me)tBu2

Coordination Chemistry of P‐rich Phosphanes and Silylphosphanes. XVII [1] [Co(g⁵‐Me₅C₅)(g³‐^tBu₂PPCH–CH₃)] from [Co(g⁵‐Me₅C₅)(g²‐C₂H₄)₂] and ^tBu₂P–P=P(Me)^tBu₂ [Co(η⁵‐Me₅C₅)(η³‐^tBu₂PPCH–CH₃)] 1 is formed in the reaction of [Co(η⁵‐Me₅C₅)(η²‐C₂H₄)₂] 2 with ^tBu₂P–P 4 (generated from ^tBu₂P–P=P(Me)^tBu₂ 3 ) by elimination of one C₂H₄ ligand and coupling of the phosphinophosphinidene with the second one. The structure of 1 is proven by ³¹P, ¹³C, ¹H NMR spectra and the X‐ray structure analysis. Within the ligand ^tBu₂P¹P²C¹H–CH₃ in 1 , the angle P1–P2–C1 amounts to 90°. The Co, P1, P2, C1 atoms in 1 look like a „butterfly”︁. The reaction of 2 with a mixture of ^tBu₂P–P=P(Me)^tBu₂ 3 and ^tBu–C?P 5 yields [Co(η⁵‐Me₅C₅){η⁴‐(^tBuCP)₂}] 6 and 1 . While 6 is spontaneously formed, 1 appears only after complete consumption of 5 .     

Synthesen und Charakteristika von Heterobimetallorganika des Siliciums mit dem 2‐(Dimethylaminomethyl)ferrocenyl‐Liganden FcN (η5‐C5H5)Fe[η5‐C5H3(CH2NMe2)]—

Syntheses and characteristics of the heterobimetalorganics of the silicon with the 2‐(dimethylaminomethyl)ferrocenyl ligand FcN (η⁵‐C₅H₅)Fe[η⁵‐C₅H₃(CH₂NMe₂)]^— The heterobimetallic lithiumorganyl [2‐(dimethylaminomethyl)ferrocenyl] lithium, LiFcN, reacts with silicon(IV)‐chlorid, SiCl₄, under the formation of heterobimetallic silicon(IV) organyl [(FcN)₃SiCl] ( 1 ). The heterobimetallic organosilanol [(FcN)₃SiOH] ( 2 ) is formed at hydrolysis of 1 . A detailed characterization of the defined compounds 1 and 2 was carried out by NMR‐ rsp. mass‐spectrometry and by crystal X‐ray analysis of 2 .     

Poly[aquaneodymium(III)‐μ5‐2‐oxido‐5‐sulfonatobenzoato]

The title compound, [Nd(C₇H₃O₆S)(H₂O)]_n or [Nd(SSA)(H₂O)]_n (H₃SSA is 5‐sulfosalicylic acid), was synthesized by the hydrothermal reaction of Nd₂O₃ with H₃SSA in water. The compound forms a three‐dimensional network in which the asymmetric unit contains one Nd^III atom, one SSA ligand and one coordinated water mol­ecule. The central Nd^III ion is eight‐coordinate, bonded to seven O atoms from five different SSA ligands [Nd—O = 2.405 (4)–2.612 (4) Å] and one aqua O atom [Nd—OW = 2.441 (4) Å].     

Synthese und Kristallstruktur des heterobimetallischen Diorganozinndichlorids (FcN,N)2SnCl2 (FcN,N—: (η5‐C5H5)Fe{(η5‐C5H3[CH(CH3)N(CH3)CH2CH2NMe2]‐2}—)

Synthesis and Crystal Structure of the Heterobimetallic Diorganotindichloride (FcN, N)₂SnCl₂ (FcN, N^—: (η⁵‐C₅H₅)Fe{η⁵‐C₅H₃[CH(CH₃)N(CH₃)CH₂CH₂NMe₂]‐2}^—) The heterobimetallic title compound [(FcN, N)₂SnCl₂] ( 1 ) was obtained by the reaction of [LiFcN, N] with SnCl₄ in the molar ratio 1:1 in diethylether as a solvent. The two FcN, N^— ligands in 1 are bound to Sn through a C‐Sn σ‐bond; the amino N atoms of the side‐chain in FcN, N^— remain uncoordinated. The crystals contain monomeric molecules with a pseudo‐tetrahedral coordination at the Sn atom: Space group P2₁/c; Z = 4, lattice dimensions at —90 °C: a = 9.6425(2), b = 21.7974(6), c = 18.4365(4) Å, β = 100.809(2)°, R1_obs· = 0.051, wR2_obs· = 0.136.     

Nucleotides part XXX Chemical synthesis of adenylyl-(2′ → 5′)-adenylyl-(2′ → 5′)-8-azidoadenosine,and activation and photoaffinity labelling of RNase L by [32P]p5′A2′p5′A2′p5′N38A

The chemical synthesis of adenylyl-(2′–5′)-adenylyl-(2′–5′)-8-azidoadenosine ( 15 ) was performed by the phosphotriester approach. Enzymatic phosphorylation of 15 by [γ-³²P]ATP led to the corresponding labelled 5′-monophosphate 16 . Photoinsertion of 16 took place on UV irradiation by covalent cross linking to a protein of M_r 80 K known to be RNase L. Radiobinding and core-cellulose assays as well as photoaffinity labelling experiments with 16 are described.     

Bis(5‐phenyltetrazol‐2‐yl)methane

In the title compound, alternatively named 5,5′‐diphenyl‐2,2′‐methyleneditetrazole, C₁₅H₁₂N₈, the dihedral angles between the tetrazole and benzene rings in the two 5‐phenyl­tetrazole fragments are 2.45 (6) and 10.01 (9)°. There is weak intermolecular C—H?N hydrogen bonding involving the H atoms of the methyl­ene groups, which is responsible for the formation of two‐membered aggregates. C—H?π interactions in the crystal structure are discussed.     

Energetic Derivatives of 4, 4′,5, 5′‐Tetranitro‐2, 2′‐bisimidazole (TNBI)

4, 4′,5, 5′‐Tetranitro‐2, 2′‐bisimidazole (TNBI) was synthesized by nitration of bisimidazole (BI) and recrystallized from acetone to form a crystalline acetone adduct. Its ammonium salt ( 1 ) was obtained by the reaction with gaseous ammonia. In order to explore new explosives or propellants several energetic nitrogen‐rich 2:1 salts such as the hydroxylammonium ( 3 ), guanidinium ( 4 ), aminoguanidinium ( 5 ), diaminoguanidinium ( 6 ) and triaminoguanidinium 7 4, 4′,5, 5′‐tetranitro‐2, 2′‐bisimidazolate were prepared by facile metathesis reactions. In addition, methylated 1, 1′‐dimethyl‐4, 4′,5, 5′‐tetranitro‐2, 2′‐bisimidazole (Me₂TNBI, 8 ) was synthesized by the reaction of 2 and dimethyl sulfate. Metal salts of TNBI can also be easily synthesized by using the corresponding metal bases. This was proven by the synthesis of pyrotechnically relevant dipotassium 4, 4′,5, 5′‐tetranitro‐2, 2′‐bisimidazolate ( 2 ), which is a brilliant burning component e.g. in near‐infrared flares. All compounds were characterized by single crystal X‐ray diffraction, NMR and vibrational spectroscopy, elemental analysis and DSC. The sensitivities were determined by BAM methods (drophammer and friction tester). The heats of formation were calculated using CBS‐4M electronic enthalpies and the atomization method. With these values and mostly the X‐ray densities different detonation parameters were computed by the EXPLO5 computer code. Due to the great thermal stability and calculated energetic properties, especially guanidinium salt 4 could be served as a HNS replacement.     

Carbocyclic 5′‐norcytidine (5′‐norcarbodine)

A preparation of (1′R,2′S,3′R,4′S)‐1‐(2′,3′,4′‐trihydroxycyclopent‐1′‐yl)‐lH‐cytosine (5′‐norcarbodine, 3 ) has formally been achieved in 2 steps from (+)‐(1R,4S)‐4‐hydroxy‐2‐cyclopenten‐1‐yl acetate ( 4 ) and cytosine. The L‐like enantiomer of 3 (that is, 6 ) is also reported using the enantiomer of 4 (that is, 7 ). In evalu ating 3 and 6 for antiviral potential against a number of viruses, compound 3 was found to have activity towards Epstein‐Barr virus (EBV).